Biology and validation of PCSK9 as a novel target to lower LDL-C
Prof. John JP Kastelein
Educational information
The programme was CME accredited by EBAC
Lecture by Prof. John Kastelein, Amsterdam, The Netherlands, held during EBAC accredited symposium 'Managing Innovations in lipid management: Evolving insights and implications from PCSK9 research' held during ESC2014 in Barcelona
Share this page with your colleagues and friends: